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Organic anion transporter 1 (OAT1) is localized in the basolateral membrane of the proximal tubule in the kidney and plays an essential role in
eliminating a wide range of organic anions, preventing their toxic effects on the body. Structural and functional studies of the transporter would be
greatly assisted by inexpensive and rapid expression in the yeast Saccharomyces cerevisiae. The gene encoding rat OAT1 (rOAT1) contains many
yeast non-preferred codons at the N-terminus and so was modified by fusion of the favored codon sequence of a hemagglutinin (HA) epitope
preceding the start codon. The modified gene was cloned into several yeast expression plasmids, both integrative and multicopy, with either ADH1
promoter or GAL1 promoter in order to find a suitable expression system. Compared with the wild type gene, a substantial increase in rOAT1
expression was achieved by modification in the translational initiation region, suggesting that the codon chosen at the N-terminus influenced its
expression. The highest inducible expression of rOAT1 was obtained under GAL1 promoter in 2 A plasmid. A large fraction of rOAT1 was
glycosylated in yeast, unaffected by growth temperature. The recombinant yeast expressing rOAT1 showed an increase in the uptake of p-
aminohippurate (PAH) and this showed a positive correlation with rOAT1 expression level. Location of rOAT1 predominantly in the yeast plasma
membrane confirmed correct processing. The importance of glycosylation for rOAT1 targeting was also shown. To our knowledge, this is the first
successful functional expression of rOAT1 in the yeast S. cerevisiae.
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Numerous endogenous and exogenous organic anions can
have harmful effects on the body. These compounds are either
transformed into less active metabolites or are excreted via
transport processes by excretory organs such as the kidney,
liver and intestine. In the kidney, for example, a multitude of
organic anions of varied structure are efficiently eliminated by
transport systems in the proximal tubule [1].
rOAT1 is an essential component of the renal secretion
system that mediates sodium-independent uptake of anionic
compounds across the basolateral membrane into the proximal
tubule in exchange for intracellular glutarate. The substrate
specificity of rOAT1 is remarkably wide [2] and a variety of0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2005.09.021
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E-mail address: sccbc@mahidol.ac.th (C. Boonchird).drugs have also been demonstrated to be transported by it [3,4].
Efflux of these substances through the luminal membrane is
presumed to occur via anion exchangers and/or electrochemical
gradient-driven facilitated transporters [1,2,4,5].
So far, structural and functional studies of rOAT1 have been
hampered by the lack of a sufficient amounts and heterologous
expression in a functional form would be a possible way to solve
this problem. Although rOAT1 has been functionally expressed
in Xenopus leavis oocytes [6,7], manipulation of the test system
is time consuming and the protein yield is often poor. The yeast
Saccharomyces cerevisiae has been successfully used for
expression of several mammalian membrane proteins such as
cystic fibrosis transmembrane conductance regulator [8], human
multidrug resistance [9], vesicular monoamine transporter [10],
dopamine receptor [11], and glucose transporter [12] and could
thus be considered as a possible vehicle for inexpensive and
rapid production of rOAT1.ta 1720 (2005) 44 – 51
http://www
Fig. 1. The first 17 codons encoding the N-terminus of rOAT1 (A). The HA-epitope and the fusion site (B). represents codon preferred by yeast, 4 indicate a non-
preferred codon, BamHI site is underlined and dot letters show a Kozak consensus sequence upstream of the rOAT1 start codon (italic). Open bars represents
boundary of the HA-epitope.
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membrane proteins in S. cerevisiae are the strong codon usage
bias in yeast and differences in post-translational modification
between yeast and mammalian systems, especially for glyco-
sylation. Examination of codon usage at the 5V end of rOAT1
revealed a trend of yeast non-favored codons. To overcome this
problem, we used the strategy of constructing HArOAT1 (Fig.
1) to contain the readily translatable HA (hemagglutinin)
epitope fused upstream of the rOAT1 start codon.
To find a suitable expression system for rOAT1, the HA-
fusion rOAT1 gene was cloned into different yeast expression
plasmids, both integrative and multicopy, with the constitutive
ADH1 promoter or the GAL1 inducible promoter. The effect of
growth temperature on glycosylation of yeast-expressed rOAT1
was also studied. In addition, the transport ability and plasma
membrane targeting of the protein were examined to determine
whether heterologously expressed rOAT1 retained structural
and functional characteristics.
2. Materials and methods
2.1. Vector constructions
rOAT1 cDNA (accession number: AB004559, GenBanki nucleotide data
bases) was kindly provided by Prof. H. Endou (Kyorin University, Japan) in
plasmid pSPORT1. The rOAT1 ORF was previously cloned into pBlueScript
SK¯ between the BamHI and EcoRI sites to yield pBPII (B. Punlungka
unpublished data). The BamHI–EcoRI cDNA fragment for rOAT1 was
extracted from pBPII and inserted into pFA6a–TRP1–pGAL1–3HA
(obtained from Dr. H. Qui, NIH). The newly constructed plasmid named
pFA6a–TRP1–pGAL1–HArOAT1 harbored the rOAT1 ORF modified at the
translation initiation region by fusion with two copies of the HA encoding
sequence.
The HA–rOAT1 fusion gene (HArOAT1) was amplified by PCR using a
forward primer designed to introduce the sequence TTAGAGCTCAAAATG
(SacI site underlined, Kozak consensus sequence in italics) to the 5V end and a
reverse primer designed for addition of an EcoRI site immediately downstream
of the stop codon. The resulting blunt-end PCR fragment was digested with
EcoRI, to generate a 3V EcoRI cohesive end before it was ligated into pSP72vector between EcoRI and EcoRV restriction sites. The correct sequence of the
PCR amplified HArOAT1 gene could then be confirmed by DNA sequencing
using T7 and SP6 primers. The SacI restriction site of pSP72 located next to the
EcoRI cloning site could be utilized for subcloning the gene into several
expression plasmids. Since the PCR product was rather long, only the modified
N- and C-terminal sequences were verified by a single pair of primers. Finally,
the middle fragment from the BstEII to NheI site of the PCR-amplified
HArOAT1 was replaced with the original HArOAT1 cDNA from PBPII to yield
plasmid pSP72–HArOAT-1.
The parent vector for construction of an integrative HArOAT1 expression
plasmid was generated from insertion of an ADH1 promoter-multicloning site-
CYC1 terminator cassette from pTB326 vector (kindly provided by Dr. H. Qui,
NIH) into the integrative vector YIPBssHII 211 (obtained from Dr. J. Hauf,
Technical University of Darmstadt, Germany). To facilitate subcloning of
genes, some restriction sites in YIPBssHII 211 corresponding to the multi-
cloning site of pTB326 firstly had to be removed. YIPBssHII 211 was digested
with BamHI and EcoRI to cleave out SacI, KpnI and SmaI restriction sites,
then treated with Mung bean nuclease to destroy BamHI and EcoRI restriction
sites. The blunt ends of the linearized plasmid were then ligated together before
insertion of the SphI–XbaI fragment of the promoter– terminator cassette from
pTB326, yielding the integrative yeast expression plasmid YIP211-1a. Then,
the SacI fragment of HArOAT1 from pSP72–HArOAT1-1 was ligated into the
parent vector YIP211-1a to create the HArOAT1 integrative plasmid pSSI (Fig.
2). By ligation of the same fragment into pTB326, the HArOAT1 multicopy
plasmid pSSIV (Fig. 2) was obtained. The multicopy plasmid pSSIII (Fig. 2)
for GAL1-inducible expression of HArOAT1 was generated by insertion of the
gene fragment extract from pSP72–HArOAT1-1 into pYES2 vector (Invitro-
gen) between EcoRI and SacI sites. The wild type rOAT1 gene extracted from
pBPII by digestion with BamHI and EcoRI was also cloned into pYES2 to
yield plasmid pSSII (Fig. 2).
2.2. Strains and media
Escherichia coli strain DH5a ( Ff80dlacZD(lacZYA–argF)u169 deoR,
recA1, end A1, hsdR17(rK, mK+), SupE44, E-thi-1,gyrA96, rec1A1) was
used for all bacterial work. The S. cerevisiae protease deficient strain BJ5462
(MATa, ura3–5, trp1 leu2D1, his3D200, pep4::HIS3, prb1D1 1.6R, can1,
GAL) (Yeast Genetic Stock Center, University of California) was used
throughout the study. Untransformed yeast cells were grown in SD minimal
medium containing 0.67% (w/v) yeast nitrogen base without amino acids
(DIFCO Laboratories), 2% (w/v) d-glucose supplemented with an amino acid
mixture. The same medium supplemented with an amino acid mixture lacking
uracil or lacking tryptophan was used for growing cells transformed with
Fig. 2. Physical maps of rOAT1-expressing yeast plasmids. The integrative plasmid pSSI is URA3 selectable and encodes the HA-fusion rOAT1 under control of the
constitutive ADH1 promoter. In the TRP1-selectable 2 A plasmid pSSIV, expression of HArOAT1 is also controlled by ADH1 promoter. The galactose-inducible
GAL1 promoter was used to control expression of HA-modified rOAT1 and wild type rOAT1 in the multicopy plasmid with URA3 selectable marker pSSIII and
pSSII, respectively. CYC1 transcriptional terminator was used in all plasmids.
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additional 2% (w/v) Bacto-Agar (DIFCO Laboratories).
2.3. Transformation and culture conditions
Yeast cells were transformed by the lithium acetate method described by I
to [13] with some modifications [14]. Transformants were identified by
auxotrophic selection. All experimental cultures were inoculated at an OD660
of 0.01 from actively growing pre-cultures. Throughout the experiments,
cultivation of transformants for gene expression under control of the
constitutive promoter ADH1 was performed using SD medium containing
glucose as the sole carbon source. For inducible expression under control of
GAL1 promoter, cells were grown in SD medium using 2% raffinose as the
carbon source until OD660 reached 0.6–0.8 units (early exponential phase), at
which time expression was induced by addition of galactose to a final
concentration of 2%. Unless indicated otherwise, the cultures were allowed to
grow at 30 -C with constant agitation (200 rpm).
2.4. Isolation of crude yeast membranes and plasma membranes
Yeast cells were grown as above, and crude cellular membranes were
prepared by a glass bead lysis protocol [9]. Plasma membranes were purified by
the acid precipitation method of Goffeau and Dufour [15]. Protein concentra-
tions were measured by the Bradford method [16].
2.5. Deglycosylation
Endoglycosidase H deglycosylation of proteins was performed as described
by Imamura [17] with some modifications. Five Al of 200 mM NaH2PO4, pH5.5 and 0.2% (w/v) SDS were added to 20 Ag proteins from yeast plasma
membrane extracts. Then 10 mU of endoglycosidase H was added and samples
were incubated for 12 h at 37 -C.
2.6. Western blots
Twenty Ag protein samples were subjected to 10% SDS-PAGE gel and run
at 110 V for about 2 h, followed by transfer onto polyvinylidene difluoride
membranes at 0.1 Amp overnight. The membranes were then washed with
TBST (20 mM Tris–HCl pH 7.5, 150 mM NaCl and 0.05% (v/v) Tween 20)
for 30 min, blocked with 5% skim milk in TBST for 1 h with agitation.
Afterward, membranes were incubated with anti-OAT1 rabbit polyclonal
antibody (1:5000 dilution) or anti-HA mouse monoclonal antibody (1 Ag/ml),
for 3 h with gentle agitation. After washing 3 times in TBST (5 min each),
membranes were incubated in 1:5000 dilution of anti-rabbit or anti-mouse IgG
AP conjugated for 1 h with gentle agitation, washed 3 times in TBST and 2
times in TBS (20 mM Tris–HCl pH 7.5 and 150 mM NaCl) to remove Tween
20. The BCIP/NBT kit (Zymed) was employed for protein detection.
2.7. Anion transport assay
Recombinant cells were cultured for expression of rOAT1 as described
above, harvested at mid exponential phase (GAL1 inducible expression) or late
exponential phase (ADH1 constitutive expression), and washed once with
Dulbecco’s phosphate buffer saline (137 mM NaCl, 3 mM KCl, 1.5 mM
KH2PO4, 8mMNa2HPO4, 1mMCaCl2, and 0.5mMMgCl2) supplementedwith
0.15 M d-glucose [9], pH 7.4 that was also used as transport buffer. The cells
were then resuspended to 68 OD66020 Al1 for one reaction with the same
buffer containing 1 mM glutarate in the presence or absence of 2 mM probenicid
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buffer, uptake experiments were initiated by rapidly mixing 20 Al of cell
suspension with 80 Al of transport buffer containing 2 AM [14C]PAH (0.1 mCi/
ml). At specific times, reactions were stopped by addition of 1 ml ice-cold
transport buffer and the cells were trapped by filtering through Whatman GF/C
filters. The filters were washed five times with 1 ml ice-cold transport buffer and
trapped radioactivity was quantified by liquid scintillation spectrometry.
3. Results
3.1. rOAT1 is expressed in yeast only when HA is fused
preceding its N-terminus
Examination of codon usage at the 5V end of rOAT1
revealed that the first 17 codons encoding the N-terminus
included at least 8 codons seldom used in yeast for highly
expressed proteins (Fig. 1). To test whether an intrinsic
determinant within the gene impeded rOAT1 expression, 21
codons encoding 2 copies of HA epitope were fused in frame
preceding the start codon of rOAT1. This created HArOAT1
that contained only 4 yeast non-favored codons.
Since expression of foreign membrane proteins may interfere
with cellular process andmay affect cell growth and viability, the
HA-modified rOAT1 gene was cloned into different yeast
expression plasmids that allowed control of expression levels.
As detailed in Materials and methods, four types of plasmids
were constructed. All plasmids were introduced by transforma-
tion into yeast strain BJ5462. Expression of rOAT1 in the yeast
plasma membrane fraction was assessed by Western blot using
polyclonal antibody directed against the carboxy terminus of theFig. 3. Expression of the N-terminal modified rOAT1 in yeast. Plasma membranes
pYES2; with the wild type rOAT1 plasmid pSSII; and with the HA-fusion rOAT1 (H
subjected to SDS-PAGE and immunoblotted with polyclonal antibody raised againtransporter. No immunoreactive material was detected in plasma
membrane prepared from any control strains transformed with
parental plasmids YIP211-1a, pTB326 or pYES2 (Fig. 3 lanes 1,
2, 3), or in the strain that carried the wild type rOAT1 expression
plasmid pSSII (Fig. 3 lane 4). Addition of HA to the 5V end
changed the expression of rOAT1. The HA-fusion rOAT1
protein encoded by pSSI, pSSIV and pSSIII (Fig. 3 lanes 5, 6,
7) migrated on SDS-PAGE with apparent molecular masses of
60–88 kDa, which was in good agreement with the molecular
mass rOAT1 predicted from the amino acid sequence (60 kDa)
[2,7,18] and with the molecular mass of glycosylated rOAT1
protein detected in rat kidney with the same antibody (77.8 kDa)
[19]. These results indicated the importance of codons at the N-
terminus for expression of rOAT1. By N-terminal fusion of short
sequence encoding yeast-favored codons, rOAT1 was able to be
expressed in yeast. Furthermore, as determined by signal
intensity, the highest expression level of HArOAT1 came from
GAL1 inducible promoter in the high copy plasmid pSSIII; while
the constitutive promoter ADH1 in the integrative plasmid pSSI
showed the least expression level. The same result was also
observed when Western blot was performed using mouse
monoclonal antibody against HA epitope (data not shown).
The small proteins found in the rOAT1-expressed strains might
come from protease degradation of rOAT1. This was supported
by a large number of predicted proteasomal cleavage sites in
rOAT1 protein.
Influenza virus hemagglutinin has a signal peptide that
mediates translocation of the protein across the endoplasmic
reticulum (ER) membrane. Addition of this transport signalwere prepared from yeast cells with only empty vector YIP211-1a, pTB326 or
ArOAT1) plasmid pSSI, pSSIV, pSSIII. 20 Ag proteins from each sample were
st C-terminus of rOAT1.
Fig. 4. rOAT1 is glycosylated in yeast. 20 Ag endo H-treated and untreated
proteins from the cells carrying plasmid pSSI, pSSIV, or pSSIII grown at 30 -C
and 16 -C (A) as compared with the 16 -C-growing cells (B), were detected by
Western blot using monoclonal antibody against HA epitope.
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carboxypeptidase Y (CPY) efficiently directed the protein to
the ER in a mammalian expression system [20]. In silico
prediction of subcellular localization suggested that 66.7% of
the wild type rOAT1 was located in the ER and only 33.3% in
the plasma membrane. HA insertion apparently changed the
predicted localization of rOAT1. An almost 2-fold increase in
plasma membrane targeting (65.2%) was predicted for the HA-
fusion protein and only small fractions should have been seen
in the ER, Golgi cisternae, vacuolar membranes and nuclear
membrane. Immunoblots of total cellular extract with both
OAT1 and HA antibody (data not shown) showed the same
banding pattern as observed with the plasma membrane.
Detection of rOAT1 protein was only in the total cell extract
of the HA-rOAT1 recombinant yeast confirmed the role of HA
in the enhancement of rOAT1 expression rather than plasma
membrane targeting.Fig. 5. The rOAT1 expressed in yeast is in functional form [14C] PAH uptake into y
plasmid pSSI, pSSIV or pSSIII are compared with the uptake in control cells wit
meanTS.E. value of accumulated [14C] PAH measured for 10 min in three indepe
controls.3.2. rOAT1 is glycosylated in yeast, unaffected by growth
temperature
The native rat OAT1 is glycosylated with up to 17 kDa of
carbohydrate [2]. It has been suggested that this carbohydrate is
required for sorting of OAT1 to the plasma membrane. Many
mammalian membrane proteins expressed in yeast are not
glycosylated [9,21–23]. To determine whether the yeast-
expressed rOAT1 was glycosylated, plasma membrane isolated
from three rOAT1 recombinant strains were treated with
enzyme endoglycosidase H, which cleaves the entire high
mannose and some hybrid oligosaccharide structure at the
glucosamine linkage of N-linked carbohydrates. Immunoblot
analysis using the anti-HA monoclonal antibody showed that
upon treatment with endoglycosidase H, the electrophoretic
mobility of rOAT1 was altered. The apparent molecular masses
from over 60 kDa to 88 kDa were reduced mostly to the
unglycosylated size of 60 kDa after deglycosylation (Fig. 4).
These results indicated that a large fraction of rOAT1 was
glycosylated at several levels in yeast.
It has been suggested that an important function of N-linked
glycosylation is the quality control for correct protein folding
in the endoplasmic reticulum (ER) [24]. Since protein folding
and stability often favor low temperatures, glycosylation of
rOAT1 in yeast grown at low temperature was investigated.
The similar band pattern in immunoblot of the plasma
membrane prepared from rOAT1 recombinant strains grown
at 30 -C and 16 -C both before and after endoglycosidase H
treatment (Fig. 4) indicated the unaltered glycosylation at
different temperatures.east cells carrying plasmid pSSII and into the rOAT1 expressing cells carrying
h parent vectors YIP211-1a, pTB326 or pYES2. Each column represents the
ndent experiments. *P <0.05; **P <0.01 indicate significant differences from
Fig. 6. Localization of rOAT1 in yeast cells. Western blot of plasma membranes
(PM), crude cellular membranes (CR), and soluble fractions (SL) prepared from
rOAT1 recombinant strains carrying plasmid pSSI, pSSIV and pSSIII, using
monoclonal antibody against HA epitope. Each lane contains 20 Ag of protein.
S. Sawamiphak et al. / Biochimica et Biophysica Acta 1720 (2005) 44–51 493.3. Yeast-expressed rOAT1 is able to transport p-aminohip-
purate (PAH)
To assess the capability of the yeast-expressed rOAT1 to
mediate organic anion exchange, the model substrate PAH was
chosen. rOAT1 recombinant strains and control strains carrying
only parent vector were cultured for either constitutive or
inducible expression of rOAT1. The cells were then loaded
with 20 AM [14C] PAH and assayed for anion uptake by
measuring the influx of radioactive PAH in exchange for
intracellular glutarate [6] (Fig. 5). No apparent difference in the
PAH uptake was observed between cells with the wild type
rOAT1 plasmid pSSII and those with pYES2 (control cells). By
contrast, recombinant yeast carrying the high copy plasmid
pSSIV showed very much higher PAH uptake) than control
cells carrying parent vector pTB326. Cells carrying pSSIII
(highest expression of rOAT1) showed a 2-fold increase in
PAH uptake when compared to pYES2-carrying cells. There
was a positive correlation between rOAT1 expression level
(determined by intensity of 60–88 kDa bands detected in
Western blots) and PAH uptake ability in each recombinant
strain.
An inhibition study was also performed in order to confirm
the specificity of PAH transport by heterologously expressed
rOAT1. In the presence of 2 mM probenecid, a classical
inhibitor of the uptake system, the amount of PAH taken up by
all HArOAT1 recombinant strains was substantially reduced
(Table 1). Accumulated PAH in control cells that showed no
detectable level of rAOT1 was also reduced in the presence of
probenecid. Many intrinsic yeast anion transporters are known
to have wide ranges of substrate specificity. The inhibition
study suggested that the host yeast S. cerevisiae strain BJ5462
had its own transport mechanism for PAH and that probenecid
was also able to inhibit that system (Table 1).
3.4. rOAT1 targets plasma membrane
Previous functional assays supported the possibility that
rOAT1 is expressed at the cell surface where it mediates PAH
entrance into cells. To determine the location of rOAT1 in
recombinant yeast strains, Western blot analysis of various
cellular fractions was performed (Fig. 6). In all rOAT1
recombinant strains, the greatest amount of rOAT1 protein
was detected in the plasma membrane. The same quantity of
protein from crude membrane fractions that included both
plasma membranes and organelle membranes showed lower
levels of rOAT1. A relatively small amount of the transporter
was found in the soluble fraction. Interestingly, the presence of
only the unglycosylated protein (60 kDa) in the intracellularTable 1
Amount of [14C] PAH accumulated in recombinant yeasts in the presence and abse
PAH uptake (pmole/OD/ml) YIP211-1a pYES2 pTB3
Recombinant yeast carrying plasmid
Without Probinicid 1.932T0.07 1.672T0.15 1.965
With Probinicid 0.145T0.07 0.221T0.19 0.108
Each value represents the meanTS.E from triplicate experiments. The paired resultsfluid (i.e., soluble fraction) is in agreement with the suggestion
that glycosylation is important for OAT1 targeting to the
plasma membrane.
4. Discussion
The present study demonstrated that codon usage at the N-
terminus of the rat organic anion transporter 1 (rOAT1) is
important for the successful expression of rOAT1 in the yeast
S. cerevisiae. The use of synonymous codons in S. cerevisiae is
strongly biased [25], mostly due to abundances of different
tRNA species [26] and it has been suggested that the efficiency
of protein synthesis is increased when required tRNA are not
limited. In addition, translation efficiency may also affect the
stability of the mRNA transcript. Preferred codons therefore
improve both transcriptional and translational processes in
protein expression [10]. By synthesizing an ideal gene with
yeast preferred codons, successful expression of malarial
parasite integral membrane protein Pfcrt in yeast was achieved
[27]. Study on the role of biased codon usage in expression of
phoshoglycerate kinase (PGK1) gene [28] showed that
replacement of major codons at the 5V end of the coding
sequence with synonymous minor ones, substantially de-
creased expression. Instead of substituting minor codons with
major codons, we fused an HA sequence consisting of mostly
yeast-preferred codons preceding the start codon of rOAT1 in
order to simplify initiation of translation. We found that rOAT1
was expressed in yeast with this modification only (Fig. 3).
This method has proven useful in a previous study on
expression of rat and bovine vesicular monoamine transporters
(rVMAT1 and bVMAT2, respectively) in yeast [10]. In
addition, we found that the best rOAT1 expression was
obtained with a multicopy plasmid in which the expression
was controlled by the inducible promoter GAL1 (Fig. 3).
The apparent sizes of the yeast-expressed rOAT1 varied
from 60 to 88 kDa. Treatment with endoglycosidase H
demonstrated that those proteins of over 60 kDa were
glycosylated (Fig. 4). Although S. cerevisiae is able to
glycosylate proteins, it has been shown that oligosaccharidence of 2 mM probenicid
26 pSSI pSSII pSSIII pSSIV
T0.11 2.260T0.11 1.566T0.02 3.351T0.12 2.693T0.22
T0.05 0.182T0.13 0.228T0.12 0.184T0.04 0.324T0.15
in each column were all significantly different ( P <0.001) by Student’s t test.
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versions in mammalian cells [29,30]. Usually, yeast makes
extensive mannosylation [31]. Since glycosylated rOAT1
found in the rat kidney is about 77 kDa [17], the larger protein
detected in the yeast plasma membrane may have resulted from
hypermannosylation.
The effect of cultivation temperature on protein expression
and post-translational, modification has been reported for
expression of rVMAT1 in yeast [10]. By lowering cultivation
temperatures, expression of rVMAT1 was remarkably im-
proved and the unglycosylated protein underwent core glyco-
sylation. In contrast to rVMAT1, glycosylation and expression
level of rOAT1 were the same at 30 -C and 16 -C.
Molecular mechanisms that determine membrane localiza-
tion of proteins in S. cerevisiae are not well understood, but the
same principles seem to govern membrane trafficking in yeast
and higher eukaryotes. An important factor effecting mem-
brane targeting is protein folding. Only proteins that are
correctly folded leave the ER and move forward into the Golgi.
Misfolded proteins undergo ER-associated degradation and the
process involves dislocation of the cargo proteins followed by
ubiquitination and proteolytic degradation [32]. Protein mod-
ification is associated with folding in the ER and glycosylation
may be required for correct folding. Control of proper folding
may be a major purpose of modifications. For example,
inhibition of glycosylation has been demonstrated to lead to
protein misfolding followed by degradation in the ER [32].
However, carbohydrate moieties have also been shown to serve
as transport signals for targeting the plasma membrane.
Unglycosylated, secretory rat growth hormone fused to the
transmembrane and cytosolic domains of vesicular stromatitis
virus G protein was blocked in the Golgi complex and unable
to reach the plasma membrane. Insertion of N-glycosylation
sites into an extracellular domain can enable a protein to target
the cell surface [33]. In epithelial Madin-Darby Canine kidney
cells, the glycosylated form of rat growth hormone was
secreted through the apical membrane, whereas the nonglyco-
sylated native form was randomly secreted both apically and
basolaterally [34]. The role of O-glycosylation as a membrane
transport signal has also been displayed in the study of the
yeast integral membrane protein Fus1p that is involved in cell
fusion during yeast mating [35]. Insertion of the Fus1
ectodomain containing several potential O-glycosylation sites
between the N-terminal part of invertase and the transmem-
brane domain of Fus1p altered the localization of the chimeric
protein and it accumulated extracellularly. In the mutant yeast
pmt4D that is unable to glycosylate proteins, the chimeric
protein was blocked in the Golgi complex.
The role of N-linked glycosylation in plasma membrane
targeting of OAT1 has been clearly demonstrated. Removal of
all N-glycosylation sites from mouse and human analogs of
OAT1 (mOAT1 and hOAT1, respectively) by replacing
asparagine with a glutamine residue resulted in failure to target
to the plasma membrane and accumulation intracellular
compartments [36]. This was in good agreement with previous
results of the same group showing that treatment of mOAT1-
expressing COS-7 cells with tunicamycin to inhibit N-linkedglycosylation resulted in failure of protein translocation to the
plasma membrane [37]. Examination of rOAT1 localization in
recombinant yeasts strongly supports these results. Glycosy-
lated OAT1 was found exclusively in the yeast plasma
membrane while the unglycosylated protein was found in the
intracellular fluid (Fig. 6).
The possible cellular mechanisms underlying the function of
carbohydrate moieties that determine apical transport of
glycoproteins in epithelial cells have been proposed. One
model suggests that hypothetical lectins bind to the glycans and
bring the glycoproteins to transport carriers in the trans-Golgi
network [34]. Another model suggests that glycans change the
biophysical properties of proteins to facilitate the presentation
of sorting signals to their receptors [35,38].
The ability of hetorologously expressed rOAT1 to transport
PAH indicated that the structure and function of the transporter
was at least partially preserved in S. cerevisiae (Fig. 5). PAH
transport by proximal tubules in the rat kidney has been
examined by various methods, including the stopped flow
capillary perfusion method. PAH was transported into proximal
tubular cells with a Km of 0.08T0.01 mM and Vmax of
1.1T0.1 pmol s1cm1 [39]. Comparison of the transport
ability of yeast-expressed rOAT1 with the native protein in the
rat kidney requires purification and reconstitution of the protein
into synthetic vesicles for further study of transport kinetics. In
addition, it has been reported that transport function of mOAT1
and hOAT1 was almost completely lost when the putative
glycosylation site Asp-39 was disrupted. However, it was
found that this putative site was used for glycosylation only in
hOAT1 and not in the mouse homolog. In addition, disruption
of other putative glycosylation sites in both proteins had no
effect on the transport activity of either mOAT1 or hOAT1
[36]. The transport function of heterologously expressed
rOAT1 in this study was assessed using a whole cell transport
assay, in which only the function of the plasma membrane
inserted rOAT1 could be examined.
In summary, we reported the first successful expression of
functional rOAT1 protein in yeast. This will lead the way to
further studies on molecular structure and transport mechanisms
and perhaps eventually to the development of in vitro systems
for studying drug kinetics or for screening drug nephrotoxicity.
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